The Influences of Malnutrition and Inflammation Complex Syndrome in Hemodialysis Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2005 by Far Eastern Memorial Hospital.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
National Taiwan University
Information provided by:
Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier:
NCT00190125
First received: September 11, 2005
Last updated: February 6, 2009
Last verified: August 2005
  Purpose

The purpose of this study is to explore the severity of malnutrition and inflammation in Taiwanese hemodialysis patients.


Condition
Hemodialysis
Malnutrition
Inflammation
Myocardial Ischemia
Cerebrovascular Accident

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: The Influences of Malnutrition and Inflammation Complex Syndrome in Hemodialysis Patients

Resource links provided by NLM:


Further study details as provided by Far Eastern Memorial Hospital:

Estimated Enrollment: 300
Estimated Study Completion Date: August 2007
Detailed Description:

Cardiovascular disease is the major of cause of mortality of hemodialysis patients. In addition to diabetes and hypertension, malnutrition and chronic inflammation are well-known to be major risk factors of cardiovascular diseases in normal population. For detecting the malnutrition and chronic inflammation and understanding the exact influences to hemodialysis patients, we conduct this study. We will collect the biochemical parameters, inflammatory markers, lipid parameters, hematologic parameters, and genomic DNA of patients. Then we will prospectively record the hospitalization, cardiovascular events, complications of arteriovenous fistula/graft, and mortality. According to the above results, we try to explore the exact role of malnutrition and inflammation in hemodialysis patients.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients who have received hemodialysis therapy for more than three months

Exclusion Criteria:

  • Having active infection diseases now
  • Patients who have a malignancy
  • Had cardiovascular events in recent three months
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00190125

Contacts
Contact: Yu-Sen Peng, M.D. 886-2-89667000 ext 1514 taan70@yahoo.com.tw
Contact: Chih-Kang Chiang, M.D. 886-2-23123456 ext 3923 ckchiang@mail.femh.org.tw

Locations
Taiwan
Far Eastern Memorial Hospital Not yet recruiting
Pan-Chiao, Taipei country, Taiwan, 220
Contact: Yu-Sen Peng, M.D.    886-89667000 ext 1514    taan70@yahoo.com.tw   
Sub-Investigator: Chih-Kang Chiang, M.D.         
Sponsors and Collaborators
Far Eastern Memorial Hospital
National Taiwan University
Investigators
Principal Investigator: Yu-Sen Peng, M.D. Far Eastern Memorial Hospital
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00190125     History of Changes
Other Study ID Numbers: FEMH-94008
Study First Received: September 11, 2005
Last Updated: February 6, 2009
Health Authority: Taiwan: Department of Health

Keywords provided by Far Eastern Memorial Hospital:
Hemodialysis
Malnutrition
Inflammation

Additional relevant MeSH terms:
Inflammation
Malnutrition
Nutrition Disorders
Myocardial Ischemia
Coronary Artery Disease
Cerebral Infarction
Stroke
Pathologic Processes
Heart Diseases
Cardiovascular Diseases
Vascular Diseases
Coronary Disease
Arteriosclerosis
Arterial Occlusive Diseases
Brain Infarction
Brain Ischemia
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on September 18, 2014